An early improvement threshold to predict response and remission in first-episode schizophrenia

Br J Psychiatry. 2010 Jun;196(6):460-6. doi: 10.1192/bjp.bp.109.069328.

Abstract

Background: Early improvement with treatment is thought to be important in patients with first-episode schizophrenia, yet a valid definition is still outstanding.

Aims: To develop a valid definition of early improvement and test its predictive validity regarding response and remission.

Method: We examined 188 in-patients with first-episode schizophrenia. Early improvement was defined as improvement in Positive and Negative Syndrome Scale (PANSS) total score at week 2, response as a 40% PANSS total score improvement at end-point, and remission according to consensus criteria.

Results: Reasonable predictive validity of early improvement was found for a 46% PANSS total score improvement at week 2 and a 50% improvement for remission (area under the curve: response 0.707, remission 0.692). Estimated confidence intervals ranged from 26 to 62% PANSS reduction for response and remission.

Conclusions: Patients with a first episode of schizophrenia should improve by at least 30% in PANSS total score at week 2 to achieve response and remission.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Germany
  • Haloperidol / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Psychotic Disorders / drug therapy*
  • ROC Curve
  • Remission Induction / methods
  • Risperidone / administration & dosage
  • Schizophrenia / drug therapy*
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Antipsychotic Agents
  • Haloperidol
  • Risperidone